Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The final list of 70 specialised services delegated to local commissioners in England

On December 5, 2024, NHS England published a document specifying the next steps in delegating commissioning responsibilities for prescribed specialized services to local commissioners - integrated care boards (ICBs) initiated a few years ago. Historically, NHS England commissioned all prescribed specialized services. 

The final list of 70 specialized services delegated to ICBs is now published. Eleven services have been added to the 59 services that were delegated to ICBs across 3 out of 7 NHS regions since April 2024 (North West, Midlands, and East of England). From April 2025, the delegation will apply to all ICBs (n=42).

Although commissioning responsibility for all 70 services is being delegated to ICBs, commissioning accountability will continue to rest with NHS England. In this role, NHS England will continue to set consistent national standards, services specifications, and clinical commissioning policies; develop metrics and quality dashboards to support improvement, oversight, and assurance; and provide national clinical leadership, expert advice, and support to ICBs through our Clinical Reference Group infrastructure.

Approximately 100 specialized services, including all highly specialized services, will not be delegated to ICBs and will continue to be the direct commissioning responsibility and accountability of NHS England.

See the full details here and here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.